AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

70 hedge funds and large institutions have $258M invested in Autolus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 8 closing their positions.

Holders
70
Holders Change
+2
Holders Change %
+2.94%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
10
Increased
14
Reduced
24
Closed
8
Calls
$368K
Puts
–
Net Calls
+$368K
Net Calls Change
+$44K

Top Buyers

1
PBA
1
Paradigm Biocapital Advisors
New York
$33.6M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$3.18M
3
AAA
3
Affinity Asset Advisors
New York
$4.64M
4
SSA
4
Schonfeld Strategic Advisors
New York
$679K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$638K

Top Sellers

1
NCM
1
Nantahala Capital Management
Connecticut
$0
2
OAM
2
Odey Asset Management
United Kingdom
$0
3
AC
3
Armistice Capital
New York
$16.1M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
EAM
5
EdenTree Asset Management
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SOW
76
State of Wyoming
Wyoming
– -$714 -300 Closed
Northwestern Mutual Wealth Management
77
Northwestern Mutual Wealth Management
Wisconsin
– -$238 -100 Closed
1 2 3
4